Suppr超能文献

用于乳胶凝集试验的 D-二聚体特异性单克隆抗体的产生和特性。

Generation and characterization of D-dimer specific monoclonal antibodies for use in latex agglutination test.

机构信息

Doctoral School, University of Veterinary Medicine, Budapest, Hungary.

Department of Coagulation, Diagon Ltd., Budapest, Hungary.

出版信息

PLoS One. 2019 Feb 14;14(2):e0212104. doi: 10.1371/journal.pone.0212104. eCollection 2019.

Abstract

The commercially available D-dimer assays used in the clinical practice often show differences in the results, and their specificity and sensitivity are rather unsatisfactory. Our aim was to develop a new monoclonal antibody against D-dimer with a proper specificity, and estimating its suitability using in a latex agglutination diagnostic test. Monoclonal antibodies were generated using hybridoma technology. Their titer was determined by a self-developed ELISA method. The cross-reactions of the antibodies were tested. Characterization of the epitope specificity of a selected antibody was performed through digestion of D-dimer followed by Western blotting. The amino acid sequences of the active antigen fragments were determined. According to the ELISA results, 38 cell groups were constated as antibody-producing hybridomas, among them 7 gave raised titer of antibody and were cloned. Based on the cross-reaction analysis, none of the antibodies gave cross-reaction with fibrin-E and fibrinogen-E fragments but reacted with fibrin D and fibrinogen D fragments. A low cross-reaction was showed with fibrinogen and fibrin X and Y. Contrary to the others, antibody 2B9 gave no cross-reaction with fibrinogen and reacted weakly with fibrin X and Y fragments. According to the epitope analysis the antibody 2B9 binds to amino acids 94-99 and to amino acids 140-147 on the beta chain and it recognizes the amino acids 23-32 and 93-98 on the gamma chain of D-dimer. Considering the characteristics of the above mentioned monoclonal antibody 2B9, we found that it is suitable to be a basis for a D-dimer diagnostic test with proper specificity.

摘要

临床上常用的商业 D-二聚体检测方法常显示出结果的差异,其特异性和灵敏度都不尽如人意。我们的目的是开发一种具有适当特异性的新的 D-二聚体单克隆抗体,并通过乳胶凝集诊断试验来评估其适用性。使用杂交瘤技术产生单克隆抗体。通过自行开发的 ELISA 方法测定其效价。测试抗体的交叉反应性。通过 D-二聚体消化 followed by Western blotting 来测定选定抗体的表位特异性特征。确定活性抗原片段的氨基酸序列。根据 ELISA 结果,确定了 38 个细胞群为产生抗体的杂交瘤,其中 7 个产生了较高的抗体效价,并进行了克隆。根据交叉反应分析,没有抗体与纤维蛋白-E 和纤维蛋白原-E 片段发生交叉反应,但与纤维蛋白 D 和纤维蛋白原 D 片段发生反应。与其他抗体相比,抗体 2B9 与纤维蛋白原和纤维蛋白 X 和 Y 的交叉反应较低。与其他抗体不同的是,抗体 2B9 与纤维蛋白原没有交叉反应,与纤维蛋白 X 和 Y 片段的反应较弱。根据表位分析,抗体 2B9 与 D-二聚体的β链上的 94-99 位氨基酸和 140-147 位氨基酸结合,识别 γ链上的 23-32 位和 93-98 位氨基酸。考虑到上述单克隆抗体 2B9 的特点,我们发现它适合作为具有适当特异性的 D-二聚体诊断试验的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3a9/6375587/971a9c9c0965/pone.0212104.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验